Department of Hematology, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China.
State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan 430072, China.
J Med Chem. 2024 Jun 13;67(11):8791-8816. doi: 10.1021/acs.jmedchem.4c00131. Epub 2024 May 22.
The spread of the influenza virus has caused devastating pandemics and huge economic losses worldwide. Antiviral drugs with diverse action modes are urgently required to overcome the challenges of viral mutation and drug resistance, and targeted protein degradation strategies constitute excellent candidates for this purpose. Herein, the first degradation of the influenza virus polymerase acidic (PA) protein using small-molecule degraders developed by hydrophobic tagging (HyT) technology to effectively combat the influenza virus was reported. The SAR results revealed that compound with Boc-()-Lys demonstrated excellent inhibitory activity against A/WSN/33/H1N1 (EC = 0.015 μM) and amantadine-resistant strain (A/PR/8/H1N1), low cytotoxicity, high selectivity, substantial degradation ability, and good drug-like properties. Mechanistic studies demonstrated that the proteasome system and autophagic lysosome pathway were the potential drivers of these HyT degraders. Thus, this study provides a powerful tool for investigating the targeted degradation of influenza virus proteins and for antiviral drug development.
流感病毒的传播导致了全球毁灭性的大流行和巨大的经济损失。为了克服病毒突变和耐药性的挑战,需要具有不同作用模式的抗病毒药物,而靶向蛋白降解策略是这方面的优秀候选药物。在此,报道了首次使用疏水标记(HyT)技术开发的小分子降解剂降解流感病毒聚合酶酸性(PA)蛋白,以有效对抗流感病毒。SAR 结果表明,具有 Boc-()-Lys 的化合物 对 A/WSN/33/H1N1(EC = 0.015 μM)和金刚烷胺耐药株(A/PR/8/H1N1)具有优异的抑制活性、低细胞毒性、高选择性、较强的降解能力和良好的类药性。机制研究表明,蛋白酶体系统和自噬溶酶体途径是这些 HyT 降解剂的潜在驱动因素。因此,这项研究为研究流感病毒蛋白的靶向降解和抗病毒药物的开发提供了有力的工具。